{"id":"https://openalex.org/W2985651908","doi":"https://doi.org/10.1182/blood-2019-123446","title":"Daratumumab Monotherapy for Patients with Relapsed or Refractory (R/R) Natural Killer/T-Cell Lymphoma (NKTCL), Nasal Type: Updated Results from an Open-Label, Single-Arm, Multicenter Phase 2 Study","display_name":"Daratumumab Monotherapy for Patients with Relapsed or Refractory (R/R) Natural Killer/T-Cell Lymphoma (NKTCL), Nasal Type: Updated Results from an Open-Label, Single-Arm, Multicenter Phase 2 Study","publication_year":2019,"publication_date":"2019-11-13","ids":{"openalex":"https://openalex.org/W2985651908","doi":"https://doi.org/10.1182/blood-2019-123446","mag":"2985651908"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2019-123446","doi":"https://doi.org/10.1182/blood-2019-123446","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2019-123446","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101654221","display_name":"Huiqiang Huang","orcid":"https://orcid.org/0000-0001-7500-8056","observed_orcids":["https://orcid.org/0000-0001-7500-8056","https://orcid.org/0000-0002-9090-1907"]},"institutions":[{"id":"https://openalex.org/I4210146711","display_name":"Sun Yat-sen University Cancer Center","ror":"https://ror.org/0400g8r85","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210146711"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hui-qiang Huang","raw_affiliation_strings":["Sun Yat-Sen University Cancer Center, Guangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sun Yat-Sen University Cancer Center, Guangzhou, China","institution_ids":["https://openalex.org/I4210146711"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109956425","display_name":"Won-Seog Kim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802194831","display_name":"Samsung Medical Center","ror":"https://ror.org/05a15z872","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I2250650973","https://openalex.org/I2802194831"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Won-Seog Kim","raw_affiliation_strings":["Samsung Medical Center, Seol, Korea, Republic of (South)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Samsung Medical Center, Seol, Korea, Republic of (South)","institution_ids":["https://openalex.org/I2802194831"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019609523","display_name":"Ming Yao","orcid":"https://orcid.org/0000-0003-2932-0019","observed_orcids":["https://orcid.org/0000-0003-2932-0019"]},"institutions":[{"id":"https://openalex.org/I4210131804","display_name":"National Taiwan University Hospital","ror":"https://ror.org/03nteze27","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I4210131804"]}],"countries":["TW"],"is_corresponding":false,"raw_author_name":"Ming Yao","raw_affiliation_strings":["National Taiwan University Hospital, Taipei, Taiwan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Taiwan University Hospital, Taipei, Taiwan","institution_ids":["https://openalex.org/I4210131804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100719069","display_name":"Tae Min Kim","orcid":"https://orcid.org/0000-0001-6145-4426","observed_orcids":["https://orcid.org/0000-0001-6145-4426"]},"institutions":[{"id":"https://openalex.org/I2802835388","display_name":"Seoul National University Hospital","ror":"https://ror.org/01z4nnt86","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I139264467","https://openalex.org/I2802835388"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Tae Min Kim","raw_affiliation_strings":["Seoul National University Hospital, Seoul, Korea, Republic of (South)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seoul National University Hospital, Seoul, Korea, Republic of (South)","institution_ids":["https://openalex.org/I2802835388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044943032","display_name":"DocHyun Yoon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801680663","display_name":"Asan Medical Center","ror":"https://ror.org/03s5q0090","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I2801680663","https://openalex.org/I4210167194"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"DocHyun Yoon","raw_affiliation_strings":["Asan Medical Center, Seoul, Korea, Republic of (South)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Asan Medical Center, Seoul, Korea, Republic of (South)","institution_ids":["https://openalex.org/I2801680663"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059291757","display_name":"Seok\u2010Goo Cho","orcid":"https://orcid.org/0000-0002-5429-4839","observed_orcids":["https://orcid.org/0000-0002-5429-4839"]},"institutions":[{"id":"https://openalex.org/I4210160144","display_name":"The Catholic University of Korea Seoul St. Mary's Hospital","ror":"https://ror.org/056cn0e37","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I4210160144","https://openalex.org/I4405260414","https://openalex.org/I87111246"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Seok-Goo Cho","raw_affiliation_strings":["Seoul St. Mary's Hospital, Seoul, Korea, Republic of (South)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seoul St. Mary's Hospital, Seoul, Korea, Republic of (South)","institution_ids":["https://openalex.org/I4210160144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076088179","display_name":"Hyeon\u2010Seok Eom","orcid":"https://orcid.org/0000-0002-0484-2067","observed_orcids":["https://orcid.org/0000-0002-0484-2067"]},"institutions":[{"id":"https://openalex.org/I4210120052","display_name":"National Cancer Center","ror":"https://ror.org/02tsanh21","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I1290491151","https://openalex.org/I2801339556","https://openalex.org/I4210120052"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Hyeon-Seok Eom","raw_affiliation_strings":["National Cancer Center, Goyang-si, Korea, Republic of (South)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Center, Goyang-si, Korea, Republic of (South)","institution_ids":["https://openalex.org/I4210120052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030170547","display_name":"Su\u2010Peng Yeh","orcid":"https://orcid.org/0000-0001-6981-8677","observed_orcids":["https://orcid.org/0000-0001-6981-8677"]},"institutions":[{"id":"https://openalex.org/I4210126829","display_name":"China Medical University Hospital","ror":"https://ror.org/0368s4g32","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I4210126829"]}],"countries":["TW"],"is_corresponding":false,"raw_author_name":"Su-Peng Yeh","raw_affiliation_strings":["China Medical University Hospital, Taichung, Taiwan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"China Medical University Hospital, Taichung, Taiwan","institution_ids":["https://openalex.org/I4210126829"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038667383","display_name":"Soon Thye Lim","orcid":"https://orcid.org/0000-0002-0366-5505","observed_orcids":["https://orcid.org/0000-0002-0366-5505"]},"institutions":[{"id":"https://openalex.org/I4210137145","display_name":"National Cancer Centre Singapore","ror":"https://ror.org/03bqk3e80","country_code":"SG","type":"healthcare","lineage":["https://openalex.org/I4210137145"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"Soon Thye Lim","raw_affiliation_strings":["National Cancer Centre Singapore, Singapore, Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Centre Singapore, Singapore, Singapore","institution_ids":["https://openalex.org/I4210137145"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066795023","display_name":"Yuqin Song","orcid":"https://orcid.org/0000-0003-3067-5554","observed_orcids":["https://orcid.org/0000-0003-3067-5554"]},"institutions":[{"id":"https://openalex.org/I4210093964","display_name":"Peking University Cancer Hospital","ror":"https://ror.org/00nyxxr91","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210093964"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yuqin Song","raw_affiliation_strings":["Beijing Cancer Hospital, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beijing Cancer Hospital, Beijing, China","institution_ids":["https://openalex.org/I4210093964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008140692","display_name":"Shizhou Liu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shizhou Liu","raw_affiliation_strings":["Janssen (China) R&D, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen (China) R&D, Shanghai, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Grace Gao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Grace Gao","raw_affiliation_strings":["Janssen (China) R&D, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen (China) R&D, Shanghai, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101907181","display_name":"Lijia Zhang","orcid":"https://orcid.org/0000-0002-5728-6586","observed_orcids":["https://orcid.org/0000-0002-5728-6586"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lijia Zhang","raw_affiliation_strings":["Janssen (China) R&D, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen (China) R&D, Shanghai, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Min Qing","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Min Qing","raw_affiliation_strings":["Janssen (China) R&D, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen (China) R&D, Shanghai, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101468087","display_name":"Ming Qi","orcid":"https://orcid.org/0000-0002-7014-2640","observed_orcids":["https://orcid.org/0000-0002-7014-2640"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ming Qi","raw_affiliation_strings":["Janssen Research & Development, LLC, Spring House, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research & Development, LLC, Spring House, PA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100780621","display_name":"Jin Seok Kim","orcid":"https://orcid.org/0000-0001-8986-8436","observed_orcids":["https://orcid.org/0000-0001-8986-8436"]},"institutions":[{"id":"https://openalex.org/I2799970807","display_name":"Severance Hospital","ror":"https://ror.org/044kjp413","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I193775966","https://openalex.org/I2799970807","https://openalex.org/I4210160791"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Jin Seok Kim","raw_affiliation_strings":["Severance Hospital, Seoul, Korea, Republic of (South)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Severance Hospital, Seoul, Korea, Republic of (South)","institution_ids":["https://openalex.org/I2799970807"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016952242","display_name":"Yok\u2010Lam Kwong","orcid":"https://orcid.org/0000-0001-8156-6978","observed_orcids":["https://orcid.org/0000-0001-8156-6978"]},"institutions":[{"id":"https://openalex.org/I2800810863","display_name":"Queen Mary Hospital","ror":"https://ror.org/02xkx3e48","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I1294586568","https://openalex.org/I2800810863"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yok Lam Kwong","raw_affiliation_strings":["Queen Mary Hospital, Hong Kong, Hong Kong"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Queen Mary Hospital, Hong Kong, Hong Kong","institution_ids":["https://openalex.org/I2800810863"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101398299","display_name":"Jie Jin","orcid":"https://orcid.org/0000-0003-4617-2601","observed_orcids":["https://orcid.org/0000-0003-4617-2601","https://orcid.org/0000-0002-8166-9915"]},"institutions":[{"id":"https://openalex.org/I4210166576","display_name":"First Affiliated Hospital Zhejiang University","ror":"https://ror.org/05m1p5x56","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210166576"]},{"id":"https://openalex.org/I76130692","display_name":"Zhejiang University","ror":"https://ror.org/00a2xv884","country_code":"CN","type":"education","lineage":["https://openalex.org/I76130692"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jie Jin","raw_affiliation_strings":["1st Affiliated Hospital of Zhejiang University Medical College, Hangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1st Affiliated Hospital of Zhejiang University Medical College, Hangzhou, China","institution_ids":["https://openalex.org/I4210166576","https://openalex.org/I76130692"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100709250","display_name":"Yuankai Shi","orcid":"https://orcid.org/0000-0002-3342-4964","observed_orcids":["https://orcid.org/0000-0002-3342-4964","https://orcid.org/0000-0002-8685-6744"]},"institutions":[{"id":"https://openalex.org/I200296433","display_name":"Chinese Academy of Medical Sciences & Peking Union Medical College","ror":"https://ror.org/02drdmm93","country_code":"CN","type":"education","lineage":["https://openalex.org/I200296433"]},{"id":"https://openalex.org/I4210141458","display_name":"Cancer Hospital of Chinese Academy of Medical Sciences","ror":"https://ror.org/03x937183","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210141458"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yuankai Shi","raw_affiliation_strings":["Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China","institution_ids":["https://openalex.org/I200296433","https://openalex.org/I4210141458"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030040961","display_name":"Jun Zhu","orcid":"https://orcid.org/0000-0003-3479-2547","observed_orcids":["https://orcid.org/0000-0003-3479-2547"]},"institutions":[{"id":"https://openalex.org/I4210093964","display_name":"Peking University Cancer Hospital","ror":"https://ror.org/00nyxxr91","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210093964"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jun Zhu","raw_affiliation_strings":["Beijing Cancer Hospital, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beijing Cancer Hospital, Beijing, China","institution_ids":["https://openalex.org/I4210093964"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":16,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"134","issue":"Supplement_1","first_page":"1568","last_page":"1568"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.8661999702453613,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.8661999702453613,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.11150000244379044,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11811","display_name":"Cutaneous lymphoproliferative disorders research","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/daratumumab","display_name":"daratumumab","score":0.9900000095367432},{"id":"https://openalex.org/keywords/natural-killer-t-cell-lymphoma","display_name":"natural killer/T-cell lymphoma","score":0.9049999713897705},{"id":"https://openalex.org/keywords/nasal-type","display_name":"nasal type","score":0.8270000219345093},{"id":"https://openalex.org/keywords/relapsed-refractory-lymphoma","display_name":"relapsed/refractory lymphoma","score":0.9309999942779541},{"id":"https://openalex.org/keywords/cd38","display_name":"CD38","score":0.9319999814033508},{"id":"https://openalex.org/keywords/monoclonal-antibody-therapy","display_name":"monoclonal antibody therapy","score":0.8259999752044678},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.7369999885559082},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9869999885559082},{"id":"https://openalex.org/keywords/duration-of-response","display_name":"duration of response","score":0.7620000243186951},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.3869999945163727},{"id":"https://openalex.org/keywords/epstein-barr-virus-associated-lymphoma","display_name":"Epstein-Barr virus-associated lymphoma","score":0.7369999885559082},{"id":"https://openalex.org/keywords/extranodal-lymphoma","display_name":"extranodal lymphoma","score":0.6389999985694885},{"id":"https://openalex.org/keywords/simon-s-two-stage-design","display_name":"Simon two-stage design","score":0.4860000014305115}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7313161492347717},{"id":"https://openalex.org/C2781119759","wikidata":"https://www.wikidata.org/wiki/Q5222113","display_name":"Daratumumab","level":4,"score":0.5964561104774475},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5707257986068726},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4962008595466614},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4834064543247223},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.470106303691864},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.46205320954322815},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.42800551652908325},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.41381651163101196},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.35800379514694214},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.3453081250190735},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2948177456855774},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.2580817937850952},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2575022578239441},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.15892282128334045},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2019-123446","doi":"https://doi.org/10.1182/blood-2019-123446","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2019-123446","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.6100000143051147,"id":"https://metadata.un.org/sdg/1","display_name":"No poverty"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4366082830","https://openalex.org/W4229333964","https://openalex.org/W2510398184","https://openalex.org/W4233225695","https://openalex.org/W4387003806","https://openalex.org/W2605594161","https://openalex.org/W3121407702","https://openalex.org/W4391228143","https://openalex.org/W4320925653","https://openalex.org/W4310106664"],"abstract_inverted_index":{"Hui-qiang":[0],"Huang":[1],"and":[2,26,31,37,41,56,84,110,121,148,206,245,278,289,299,380,410,516,519,542,557,588,600,635,653,675],"Won-Seog":[3],"Kim":[4],"contributed":[5],"equally":[6],"to":[7,198,532,565,659],"this":[8,69,680],"work.":[9],"Introduction:":[10],"NKTCLs":[11],"are":[12,23,32,53,502],"rare,":[13],"Epstein-Barr":[14],"virus-associated":[15],"distinct":[16],"subtypes":[17],"of":[18,27,113,131,137,168,204,276,291,311,326,339,357,382,397,419,452,475,491,540,577,609,614,618,627],"peripheral":[19],"T-cell":[20],"lymphoma.":[21],"These":[22],"primarily":[24],"extranodal":[25,188],"the":[28,169,390,447,607],"nasal":[29,190],"type":[30,191],"more":[33],"common":[34,495,525],"in":[35,140,183,504,538,586,591,594,606,633,637,670,679,749],"Asia":[36],"Central/South":[38],"America":[39],"(Tse":[40],"Kwong.":[42],"Blood":[43,158],"2013.":[44],"121:4997-5005).":[45],"Outcomes":[46],"for":[47,68,87,118,211,220,236,242,273,304,434,740,745],"patients":[48,656],"(pts)":[49],"with":[50,57,106,142,176,185,314,344,470,486,570,620,648,672],"R/R":[51,143,673],"NKTCL":[52,75,144,189,365,674],"very":[54],"poor,":[55],"no":[58,558,649],"standard":[59],"therapy,":[60],"there":[61],"exists":[62],"a":[63,80,99,107,132,416,471,487],"highly":[64],"unmet":[65],"medical":[66],"need":[67],"pt":[70,404,683],"population.":[71,684],"Clinical":[72],"data":[73,164],"from":[74,128,165,363,625],"pts":[76,141,184,313,341,383,398,435,509,528,541,549,610,619,671],"suggest":[77],"CD38":[78,105,385,571,582],"as":[79,307,747],"new":[81,650],"prognostic":[82],"biomarker":[83,221],"novel":[85],"target":[86],"therapy":[88],"(Wang":[89],"et":[90,156],"al.":[91,157],"Ann":[92],"Hematol":[93],"2015.":[94],"94:1381-8).":[95],"Daratumumab":[96,736],"(DARA)":[97],"is":[98,116,737,743],"human":[100],"IgGk":[101],"monoclonal":[102],"antibody":[103],"targeting":[104],"direct":[108],"on-tumor":[109],"immunomodulatory":[111],"mechanism":[112],"action":[114],"that":[115,195,580],"approved":[117,744],"newly":[119],"diagnosed":[120],"relapsed/refractory":[122],"multiple":[123,750],"myeloma":[124],"(MM).":[125],"Interim":[126],"results":[127],"stage":[129,166,329],"1":[130,310,612],"phase":[133,173],"2":[134,167,174,330,547,655],"study":[135,175,678],"(NCT02927925)":[136],"DARA":[138,181,226,345,566,642,661],"monotherapy":[139,182,662,748],"demonstrated":[145,663],"high":[146],"tolerability":[147],"pre-specified":[149],"futility":[150,302],"criteria":[151],"were":[152,208,223,342,432,523,543,562,604],"not":[153,209,224,321,568],"met":[154,322],"(Kim":[155],"2018.":[159],"132:1617).":[160],"Here":[161],"we":[162],"present":[163],"study.":[170],"Methods:":[171],"This":[172],"Simon's":[177],"2-stage":[178],"design":[179],"evaluated":[180],"histologically":[186],"confirmed":[187],"per":[192,270],"WHO":[193],"classification":[194],"was":[196,229,258,320,349,367,376,426,454,463,479,567,583,631,645],"refractory":[197],"or":[199,252,359],"relapsed":[200],"after":[201,611],"\u22651":[202],"line":[203],"chemotherapy,":[205],"who":[207,436],"candidates":[210],"other":[212,240],"treatment":[213,400,530],"modalities.":[214],"Pts":[215],"without":[216],"available":[217],"tumor":[218,578],"samples":[219],"determination":[222],"eligible.":[225],"16":[227,243,327,334,643],"mg/kg":[228,644],"administered":[230],"by":[231],"IV":[232],"infusion":[233],"once":[234],"weekly":[235],"8":[237,448],"weeks,":[238,244],"every":[239,246],"week":[241],"4":[247,560],"weeks":[248],"thereafter":[249],"until":[250],"progression":[251,402],"unacceptable":[253],"toxicity.":[254],"The":[255,493,616],"primary":[256],"endpoint":[257],"objective":[259],"response":[260,292,316,318,453,666],"rate":[261,474,490,667],"(ORR)":[262],"based":[263,293,423],"on":[264,294,424],"blinded":[265],"independent":[266],"central":[267],"review":[268],"(BICR)":[269],"Revised":[271],"Criteria":[272],"Response":[274,430,564],"Assessment":[275],"Hodgkin":[277],"non-Hodgkin":[279],"Lymphoma":[280],"(Lugano":[281],"classification).":[282],"Additional":[283],"endpoints":[284],"included":[285],"progression-free":[286],"survival":[287,297],"(PFS)":[288],"duration":[290,451],"BICR,":[295],"overall":[296],"(OS),":[298],"safety.":[300],"Protocol-specified":[301],"criterion":[303],"ORR":[305,422],"(defined":[306],"at":[308,323,374],"most":[309,494,524],"15":[312],"complete":[315],"[CR]/partial":[317],"[PR])":[319],"interim":[324],"analysis":[325],"pts;":[328],"enrolled":[331],"an":[332,354,621,664],"additional":[333],"pts.":[335],"Results:":[336],"A":[337],"total":[338],"32":[340],"treated":[343],"monotherapy.":[346],"Median":[347,461,477],"age":[348],"56":[350],"years,":[351],"91%":[352,396],"had":[353,384,510,550],"ECOG":[355],"score":[356],"0":[358],"1,":[360],"median":[361,370,417,450],"time":[362],"initial":[364],"diagnosis":[366],"24.0":[368],"months,":[369,421],"(range)":[371],"plasma":[372],"EBV-DNA":[373,622],"baseline":[375,626],"900":[377],"(0-94,800)":[378],"kIU/L,":[379],"50%":[381,632],"expression":[386],"values":[387],"\u226550%.":[388],"At":[389,415],"clinical":[391],"cut-off":[392],"(June":[393],"4,":[394],"2019),":[395],"discontinued":[399,529],"(disease":[401],"[66%],":[403],"withdrawal":[405],"[13%],":[406],"physician":[407],"decision":[408],"[9%],":[409],"adverse":[411,499],"event":[412],"[AE;":[413],"3%]).":[414],"follow-up":[418],"16.7":[420],"BICR":[425],"25.0%":[427],"(Table":[428],"1).":[429,640],"rates":[431],"similar":[433],"received":[437],"<3":[438],"vs":[439,444],"\u22653":[440],"prior":[441],"treatments":[442],"(26%":[443],"23%).":[445],"Among":[446],"responders,":[449],"55":[455],"days":[456,465,481],"(95%":[457,466,482],"CI,":[458,467,483],"29-339":[459],"d).":[460],"PFS":[462,473],"53":[464],"32-106":[468],"d),":[469,485],"4-month":[472],"11%.":[476],"OS":[478,489],"130":[480],"94-228":[484],"6-month":[488],"40%.":[492],"(>20%)":[496],"all-grade":[497],"treatment-emergent":[498],"events":[500],"(TEAEs)":[501],"listed":[503],"Table":[505],"2.":[506],"Eighteen":[507],"(56%)":[508],"grade":[511,551,559],"3/4":[512],"TEAEs;":[513],"thrombocytopenia":[514],"(22%),":[515],"anemia,":[517],"leukopenia,":[518],"neutropenia":[520],"(16%":[521],"each)":[522],"(\u226515%).":[526],"Two":[527],"due":[531,658],"TEAEs.":[533,660],"Infusion-related":[534],"reactions":[535],"(IRRs)":[536],"occurred":[537],"63%":[539],"generally":[544],"mild:":[545],"only":[546,654],"(6%)":[548],"3":[552],"IRRs":[553,561],"(urticaria,":[554],"hypertension,":[555],"hypotension),":[556],"reported.":[563],"associated":[569],"expression:":[572],"mean":[573],"(standard":[574],"deviation)":[575],"percentage":[576,617],"cells":[579,603],"expressed":[581],"41.6%":[584],"(31.92)":[585],"non-responders":[587,638],"56.7%":[589],"(39.33)":[590],"responders.":[592],"Reductions":[593],"NK":[595],"cells,":[596],"complement":[597],"protein":[598],"C1q,":[599],"CD38+":[601],"Treg":[602],"observed":[605],"majority":[608],"cycle":[613],"DARA.":[615],"load":[623],"reduction":[624],"greater":[628],"than":[629],"25%":[630],"responders":[634],"16.7%":[636],"(Figure":[639],"Conclusions:":[641],"well":[646],"tolerated":[647],"safety":[651],"concerns,":[652],"discontinuing":[657],"encouraging":[665],"(ORR:":[668],"25%)":[669],"warrants":[676],"further":[677],"poor":[681],"prognosis":[682],"Disclosures":[685],"Kim:":[686],"Donga:":[687],"Research":[688,691,694,697,700,703,706,718,721],"Funding;":[689,692,695,698,701,704],"Kyowa-Kirin:":[690],"Roche:":[693],"Celltrion:":[696],"Novartis:":[699],"J&J:":[702],"Mundipharma:":[705],"Funding.":[707,719,722],"Kim:Novartis:":[708],"Consultancy;":[709,711,713,715],"Sanofi:":[710],"Bayer:":[712],"Takeda:":[714],"AstraZeneca:":[716],"Consultancy,":[717],"Yoon:J&J:":[720],"Lim:National":[723],"Cancer":[724],"Centre":[725],"Singapore:":[726],"Employment.":[727,733],"Qing:Janssen:":[728],"Employment,":[729],"Equity":[730],"Ownership.":[731],"Qi:Janssen:":[732],"OffLabel":[734],"Disclosure:":[735],"under":[738],"investigation":[739],"NKTCL;":[741],"daratumumab":[742],"use":[746],"myeloma.":[751]},"counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":4}],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2025-10-10T00:00:00"}